Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease.
Lämmle
Bernhard
B
Kremer Hovinga
Johanna A
JA
George
James N
JN
D051722:ADAM Proteins / Q000235:genetics / Q000276:immunology*; D000071120:ADAMTS13 Protein; D001323:Autoantibodies / Q000276:immunology*; D000939:Epitopes / Q000235:genetics / Q000276:immunology*; D005260:Female; D030342:Genetic Diseases, Inborn / Q000201:enzymology / Q000235:genetics / Q000276:immunology / Q000401:mortality / Q000628:therapy; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D008297:Male; D017434:Protein Structure, Tertiary / Q000235:genetics; D011697:Purpura, Thrombotic Thrombocytopenic / Q000201:enzymology / Q000235:genetics / Q000276:immunology* / Q000401:mortality / Q000628:therapy; D012008:Recurrence; D012307:Risk Factors; D014841:von Willebrand Factor / Q000235:genetics / Q000276:immunology
D001323:Autoantibodies; D000939:Epitopes; D014841:von Willebrand Factor; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human